遺伝子クローニングサービス市場：サービス、用途、エンドユーザー別-2025-2030年世界予測

遺伝子クローニングサービス市場は、2023年に23億8,000万米ドルと評価され、2024年には26億3,000万米ドルに達すると予測され、CAGR 11.96％で成長し、2030年には52億5,000万米ドルに達すると予測されています。

遺伝子クローニングサービスバイオテクノロジーと医学研究に不可欠な幅広い技術と応用を包含し、様々な領域での研究を促進するために遺伝物質の複製を目的としています。遺伝子クローニングの必要性は、特定の遺伝子を複製する能力によって強調され、医薬品開発、農業、遺伝子治療、個別化医療における重要な進歩を可能にしています。その用途は、医薬品、遺伝子組み換え作物のための農業、遺伝子研究のための学術など、さまざまな分野に及んでいます。バイオテクノロジー企業、研究機関、臨床研究所などの最終用途産業は、遺伝子クローニングを活用して製品や治療法を革新し、改良しています。

市場成長を促進する主な要因としては、バイオ医薬品に対する需要の高まり、クローニング技術の技術的進歩、遺伝子研究に対する投資の増加などが挙げられます。最近の動向としては、遺伝子編集の精度と効率を高めるCRISPR-Cas9技術などが注目され、大きな市場機会となっています。企業は、より費用対効果の高いクローニング技術の開発に投資し、サービス・ポートフォリオとリーチを拡大するための共同事業を模索することが推奨されます。

しかし、遺伝子操作に対する倫理的な懸念、厳しい規制の枠組み、運用コストの高さといった課題に市場は直面しています。こうした制約は、サービスの円滑な拡大を妨げる可能性があります。強固な倫理ガイドラインと規制遵守を通じて、一般市民の認識に対処し、遺伝子調査の透明性を促進することで、これらの課題を軽減することができます。

技術革新に関しては、バイオテクノロジー企業は、クローニング効率の向上、自動化とスケーラビリティによるコスト削減、クローニング結果を予測するためのAIの統合に重点を置くかもしれないです。植物ベースのクローニングや微生物システムのようなニッチ市場の調査は、新たな道を開く可能性があります。遺伝子クローニング市場の性質はダイナミックで競争的であり、急速な技術進歩と革新的なソリューションへの差し迫ったニーズによって牽引されています。新たな科学研究を活用することで、企業はこの進化する状況の最前線に位置することができ、持続可能な成長と科学の進歩への多大な貢献を確保することができます。

市場力学：急速に進化する遺伝子クローニングサービス市場の主要市場インサイトを公開

遺伝子クローニングサービス市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 生物医学およびバイオテクノロジー研究の増加
  • 遺伝子治療と個別化医療の重視の高まり
  • 創薬および薬剤開発活動の増加
• 市場抑制要因
  • 遺伝子クローニングサービスに関連する高コスト
• 市場機会
  • 遺伝子工学技術の継続的進歩
  • 農業における遺伝子クローニングの応用拡大
• 市場の課題
  • 倫理的懸念と熟練専門家の不足

ポーターのファイブフォース：遺伝子クローニングサービス市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：遺伝子クローニングサービス市場における外部からの影響の把握

外部マクロ環境要因は、遺伝子クローニングサービス市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析遺伝子クローニングサービス市場における競合情勢の把握

遺伝子クローニングサービス市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス遺伝子クローニングサービス市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、遺伝子クローニングサービス市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨遺伝子クローニングサービス市場における成功への道筋を描く

遺伝子クローニングサービス市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大の可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 生物医学およびバイオテクノロジー調査の発展
    • 遺伝子治療と個別化医療への重点の高まり
    • 医薬品の発見と開発活動の増加
  • 抑制要因
    • 遺伝子クローニングサービスに関連する高コスト
  • 機会
    • 遺伝子工学技術の継続的な進歩
    • 農業における遺伝子クローニングの応用拡大
  • 課題
    • 倫理的な懸念と熟練した専門家の不足
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 遺伝子クローニングサービス市場：サービス別

• カスタムクローニングサービス
• 遺伝子合成サービス
• 分子生物学サービス

第7章 遺伝子クローニングサービス市場：用途別

• 遺伝子発現
• 遺伝子合成
• 遺伝子治療
• ワクチン調査

第8章 遺伝子クローニングサービス市場：エンドユーザー別

• 学術・調査機関
• 臨床検査室
• 製薬・バイオテクノロジー企業

第9章 南北アメリカの遺伝子クローニングサービス市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の遺伝子クローニングサービス市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの遺伝子クローニングサービス市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Amid Biosciences
• Aragen Life Sciences Technologies
• Azenta US, Inc.
• Bio-Techne Corporation
• Canvax Reagents SL
• Cellecta, Inc.
• Charles River Laboratories International, Inc.
• Creative Biogene
• Curia
• Eurofins Scientific SE
• GenScript
• Integrated DNA Technologies, Inc.
• Lonza Group AG
• Macrogen, Inc.
• MedGenome Inc.
• Merck KGaA
• Sartorius AG
• Sino Biological, Inc.
• Synbio Technologies
• Syngene International Limited
• Takara Bio Inc.
• Telesis Bio Inc.
• Thermo Fisher Scientific Inc.
• TransGen Biotech Co., Ltd
• Twist Bioscience Corporation

LIST OF FIGURES

• FIGURE 1. GENE CLONING SERVICES MARKET RESEARCH PROCESS
• FIGURE 2. GENE CLONING SERVICES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL GENE CLONING SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS GENE CLONING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS GENE CLONING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES GENE CLONING SERVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES GENE CLONING SERVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC GENE CLONING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC GENE CLONING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA GENE CLONING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA GENE CLONING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. GENE CLONING SERVICES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. GENE CLONING SERVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. GENE CLONING SERVICES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL GENE CLONING SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. GENE CLONING SERVICES MARKET DYNAMICS
• TABLE 7. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY CUSTOM CLONING SERVICE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY GENE SYNTHESIS SERVICE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY MOLECULAR BIOLOGY SERVICE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY GENE EXPRESSION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY GENE SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY VACCINE RESEARCH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS GENE CLONING SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 26. ARGENTINA GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 28. BRAZIL GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 29. BRAZIL GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 30. CANADA GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 31. CANADA GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 32. CANADA GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 34. MEXICO GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 35. MEXICO GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 38. UNITED STATES GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 39. UNITED STATES GENE CLONING SERVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 42. ASIA-PACIFIC GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 43. ASIA-PACIFIC GENE CLONING SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 44. AUSTRALIA GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 45. AUSTRALIA GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 46. AUSTRALIA GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 47. CHINA GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 48. CHINA GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 49. CHINA GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 50. INDIA GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 51. INDIA GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. INDIA GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 53. INDONESIA GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 54. INDONESIA GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 55. INDONESIA GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 56. JAPAN GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 57. JAPAN GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 58. JAPAN GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 59. MALAYSIA GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 60. MALAYSIA GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 61. MALAYSIA GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 62. PHILIPPINES GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 63. PHILIPPINES GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 64. PHILIPPINES GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 65. SINGAPORE GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 66. SINGAPORE GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. SINGAPORE GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 68. SOUTH KOREA GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 69. SOUTH KOREA GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 70. SOUTH KOREA GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 71. TAIWAN GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 72. TAIWAN GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 73. TAIWAN GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 74. THAILAND GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 75. THAILAND GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 76. THAILAND GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 77. VIETNAM GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 78. VIETNAM GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 79. VIETNAM GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 82. EUROPE, MIDDLE EAST & AFRICA GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 83. EUROPE, MIDDLE EAST & AFRICA GENE CLONING SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 84. DENMARK GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 85. DENMARK GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 86. DENMARK GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 87. EGYPT GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 88. EGYPT GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 89. EGYPT GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 90. FINLAND GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 91. FINLAND GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 92. FINLAND GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 93. FRANCE GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 94. FRANCE GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 95. FRANCE GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 96. GERMANY GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 97. GERMANY GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 98. GERMANY GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 99. ISRAEL GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 100. ISRAEL GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 101. ISRAEL GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 102. ITALY GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 103. ITALY GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 104. ITALY GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 105. NETHERLANDS GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 106. NETHERLANDS GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 107. NETHERLANDS GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 108. NIGERIA GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 109. NIGERIA GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 110. NIGERIA GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 111. NORWAY GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 112. NORWAY GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 113. NORWAY GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 114. POLAND GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 115. POLAND GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 116. POLAND GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 117. QATAR GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 118. QATAR GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 119. QATAR GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 120. RUSSIA GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 121. RUSSIA GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 122. RUSSIA GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 123. SAUDI ARABIA GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 124. SAUDI ARABIA GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 125. SAUDI ARABIA GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH AFRICA GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH AFRICA GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 128. SOUTH AFRICA GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 129. SPAIN GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 130. SPAIN GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 131. SPAIN GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 132. SWEDEN GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 133. SWEDEN GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 134. SWEDEN GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 135. SWITZERLAND GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 136. SWITZERLAND GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 137. SWITZERLAND GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 138. TURKEY GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 139. TURKEY GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 140. TURKEY GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 141. UNITED ARAB EMIRATES GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 142. UNITED ARAB EMIRATES GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 143. UNITED ARAB EMIRATES GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 144. UNITED KINGDOM GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 145. UNITED KINGDOM GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 146. UNITED KINGDOM GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 147. GENE CLONING SERVICES MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 148. GENE CLONING SERVICES MARKET, FPNV POSITIONING MATRIX, 2023

The Gene Cloning Services Market was valued at USD 2.38 billion in 2023, expected to reach USD 2.63 billion in 2024, and is projected to grow at a CAGR of 11.96%, to USD 5.25 billion by 2030.

Gene cloning services encompass a broad range of techniques and applications vital to biotechnology and medical research, aimed at reproducing genetic materials to facilitate studies in various domains. The necessity of gene cloning is underscored by its ability to replicate specific genes, enabling crucial advancements in drug development, agriculture, gene therapy, and personalized medicine. Applications span across sectors, including pharmaceuticals, agriculture for GMOs, and academia for genetic research. End-use industries such as biotechnology companies, research institutes, and clinical laboratories leverage gene cloning to innovate and refine products and therapies.

Key factors driving market growth include the rising demand for biopharmaceuticals, technological advancements in cloning techniques, and increased investment in genetic research. Recent developments must be noted, such as CRISPR-Cas9 technology, enhancing precision and efficiency in gene editing, representing significant market opportunities. Companies are recommended to invest in developing more cost-effective cloning technologies and explore collaborative ventures to expand their service portfolios and reach.

However, the market faces challenges such as ethical concerns over genetic manipulation, stringent regulatory frameworks, and high operational costs. These limitations could hinder the smooth expansion of services. Addressing public perception and fostering transparency in genetic research through robust ethical guidelines and regulatory compliance can mitigate these challenges.

For innovation, biotech firms might focus on enhancing cloning efficiency, reducing costs through automation and scalability, and integrating AI to predict cloning outcomes. Research into niche markets like plant-based cloning and microbial systems could open new avenues. The nature of the gene cloning market is dynamic and competitive, driven by rapid technological advances and a pressing need for innovative solutions. By tapping into emerging scientific research, firms can position themselves at the forefront of this evolving landscape, ensuring sustainable growth and significant contributions to scientific advancements.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Gene Cloning Services Market

The Gene Cloning Services Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rise in biomedical and biotechnological research
  • Growing emphasis on gene therapies and personalized medicine
  • Increase in drug discovery and development activities
• Market Restraints
  • High cost associated with gene cloning services
• Market Opportunities
  • Ongoing advancements in genetic engineering techniques
  • Expanding applications of gene cloning in agriculture
• Market Challenges
  • Ethical concerns and shortage of skilled professionals

Porter's Five Forces: A Strategic Tool for Navigating the Gene Cloning Services Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Gene Cloning Services Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Gene Cloning Services Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Gene Cloning Services Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Gene Cloning Services Market

A detailed market share analysis in the Gene Cloning Services Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Gene Cloning Services Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Gene Cloning Services Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Gene Cloning Services Market

A strategic analysis of the Gene Cloning Services Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Gene Cloning Services Market, highlighting leading vendors and their innovative profiles. These include Amid Biosciences, Aragen Life Sciences Technologies, Azenta US, Inc., Bio-Techne Corporation, Canvax Reagents SL, Cellecta, Inc., Charles River Laboratories International, Inc., Creative Biogene, Curia, Eurofins Scientific SE, GenScript, Integrated DNA Technologies, Inc., Lonza Group AG, Macrogen, Inc., MedGenome Inc., Merck KGaA, Sartorius AG, Sino Biological, Inc., Synbio Technologies, Syngene International Limited, Takara Bio Inc., Telesis Bio Inc., Thermo Fisher Scientific Inc., TransGen Biotech Co., Ltd, and Twist Bioscience Corporation.

Market Segmentation & Coverage

This research report categorizes the Gene Cloning Services Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Service, market is studied across Custom Cloning Service, Gene Synthesis Service, and Molecular Biology Service.
• Based on Application, market is studied across Gene Expression, Gene Synthesis, Gene Therapy, and Vaccine Research.
• Based on End User, market is studied across Academic & Research Institutions, Clinical Laboratories, and Pharmaceutical & Biotechnology Companies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rise in biomedical and biotechnological research
    • 5.1.1.2. Growing emphasis on gene therapies and personalized medicine
    • 5.1.1.3. Increase in drug discovery and development activities
  • 5.1.2. Restraints
    • 5.1.2.1. High cost associated with gene cloning services
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing advancements in genetic engineering techniques
    • 5.1.3.2. Expanding applications of gene cloning in agriculture
  • 5.1.4. Challenges
    • 5.1.4.1. Ethical concerns and shortage of skilled professionals
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Gene Cloning Services Market, by Service

• 6.1. Introduction
• 6.2. Custom Cloning Service
• 6.3. Gene Synthesis Service
• 6.4. Molecular Biology Service

7. Gene Cloning Services Market, by Application

• 7.1. Introduction
• 7.2. Gene Expression
• 7.3. Gene Synthesis
• 7.4. Gene Therapy
• 7.5. Vaccine Research

8. Gene Cloning Services Market, by End User

• 8.1. Introduction
• 8.2. Academic & Research Institutions
• 8.3. Clinical Laboratories
• 8.4. Pharmaceutical & Biotechnology Companies

9. Americas Gene Cloning Services Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Gene Cloning Services Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Gene Cloning Services Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Amid Biosciences
• 2. Aragen Life Sciences Technologies
• 3. Azenta US, Inc.
• 4. Bio-Techne Corporation
• 5. Canvax Reagents SL
• 6. Cellecta, Inc.
• 7. Charles River Laboratories International, Inc.
• 8. Creative Biogene
• 9. Curia
• 10. Eurofins Scientific SE
• 11. GenScript
• 12. Integrated DNA Technologies, Inc.
• 13. Lonza Group AG
• 14. Macrogen, Inc.
• 15. MedGenome Inc.
• 16. Merck KGaA
• 17. Sartorius AG
• 18. Sino Biological, Inc.
• 19. Synbio Technologies
• 20. Syngene International Limited
• 21. Takara Bio Inc.
• 22. Telesis Bio Inc.
• 23. Thermo Fisher Scientific Inc.
• 24. TransGen Biotech Co., Ltd
• 25. Twist Bioscience Corporation